BMY vs ZBAI · P/E 17, rev $24.46B vs rev $620.0K
Bristol-Myers Squibb Company (BMY) versus ATIF Holdings Limited (ZBAI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
ATIF Holdings Limited (ZBAI) is a capital markets company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ZBAI revenue for 2024-07-31 was $620.0K. Net income was -$3.2M. ZBAI currently screens at market cap $18.6M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ZBAI currently screens at market cap $18.6M.
Not investment advice. Open the BMY and ZBAI stock pages for the full models.
Not investment advice.